| 51 |
31314918 | Similar effectiveness of R-CHOP-14 and -21 in diffuse large B-cell lymphoma-data from the prospective German Tumour Registry Lymphatic Neoplasms. | 2019 Nov |
1 |
| 52 |
31516154 | Erythema Gyratum Repens Associated With Diffuse B-cell Lymphoma-Report of A Rare Case. | 2019 Jul-Aug |
1 |
| 53 |
31597843 | [Diffuse large B-cell lymphoma: standard treatment and research questions]. | 2019 |
1 |
| 54 |
31832222 | Granisetron plus aprepitant versus granisetron in preventing nausea and vomiting during CHOP or R-CHOP regimen in malignant lymphoma: a retrospective study. | 2019 |
1 |
| 55 |
31852157 | A case report on the effect of rituximab on pyothorax-associated lymphoma. | 2019 Dec |
1 |
| 56 |
31868632 | Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. | 2019 Dec 21 |
1 |
| 57 |
29410666 | Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice. | 2018 |
1 |
| 58 |
29467881 | Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone. | 2018 Mar |
1 |
| 59 |
29737107 | [Intravascular Large B-cell Lymphoma: a Clinical Analysis of 17 Cases]. | 2018 Jan |
1 |
| 60 |
29963517 | Impact of rituximab and half-dose CHOP as primary therapy for untreated symptomatic Waldenström Macroglobulinemia: review of a combined regimen of rituximab with an alkylating agent. | 2018 Jun |
1 |
| 61 |
30091025 | Does the omission of vincristine in patients with diffuse large B cell lymphoma affect treatment outcome? | 2018 Nov |
1 |
| 62 |
30101910 | The Prognostic Impact of Dose-attenuated R-CHOP Therapy for Elderly Patients with Diffuse Large B-cell Lymphoma. | 2018 Dec 15 |
1 |
| 63 |
30172345 | Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study. | 2018 Sep |
1 |
| 64 |
30190020 | Alkylating Agents in the Treatment of Waldenström Macroglobulinemia. | 2018 Oct |
1 |
| 65 |
30313105 | Intravascular large B-cell lymphoma presenting as multiple stroke: A case report. | 2018 Oct |
1 |
| 66 |
30340554 | Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience. | 2018 Oct 19 |
1 |
| 67 |
30431571 | Relapsed subcutaneous panniculitis-like T cell lymphoma evaluated by FDG PET/CT: A clinical case report. | 2018 Nov |
1 |
| 68 |
30788202 | Primary Vaginal Non-Hodgkin Lymphoma. | 2018 Dec 11 |
1 |
| 69 |
26449182 | CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin. | 2017 Jun |
1 |
| 70 |
27283030 | Human Herpesvirus 8-Unrelated Primary Effusion Lymphoma-Like Lymphoma in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone. | 2017 Jan |
1 |
| 71 |
27928587 | Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment. | 2017 Mar |
1 |
| 72 |
28445949 | LMP1+SLAMF1high cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells. | 2017 Apr 11 |
1 |
| 73 |
28522441 | Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma. | 2017 Jul 27 |
1 |
| 74 |
28559645 | Comorbidity between HTLV-1-associated adult T-cell lymphoma/leukemia and verrucous carcinoma: a case report. | 2017 Mar 30 |
1 |
| 75 |
28725161 | EP300 single nucleotide polymorphism rs20551 correlates with prolonged overall survival in diffuse large B cell lymphoma patients treated with R-CHOP. | 2017 |
1 |
| 76 |
28791403 | Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas. | 2017 Oct |
1 |
| 77 |
28978846 | Molecular pathogenesis and treatment strategy in diffuse large B-cell lymphoma. | 2017 |
1 |
| 78 |
29296861 | Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma. | 2017 Nov 14 |
1 |
| 79 |
29333403 | Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphoma. | 2017 Dec |
1 |
| 80 |
24675549 | Is R-CHOP Therapy a Lymphoma Growth Factor? | 2016 Jan-Feb |
1 |
| 81 |
26834485 | ALK-positive anaplastic large cell lymphoma with prominent bone involvement in a 13-year-old boy. | 2016 |
1 |
| 82 |
26960952 | Histological improvement in salivary gland along with effector memory Th17-1 cell reduction in a primary Sjogren's syndrome patient with dermatomyositis and diffuse large B-cell lymphoma by R-CHOP therapy. | 2016 Apr |
1 |
| 83 |
26986862 | THERAPY-RELATED T/MYELOID MIXED PHENOTYPE ACUTE LEUKEMIA IN A PATIENT TREATED WITH CHEMOTHERAPY FOR CUTANEOUS DIFFUSE LARGE B CELL LYMPHOMA. | 2016 Jan-Feb |
2 |
| 84 |
26990931 | Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14). | 2016 May |
1 |
| 85 |
27034868 | Plasmablastic Lymphoma Mimicking Acute Pancreatitis. | 2016 |
1 |
| 86 |
27039799 | Phase III of Study of R-CHOP-21 vs R-CHOP-14 for Untreated Stage III and IV B-cell Non-Hodgkin's Lymphoma: a Report from Iran. | 2016 |
1 |
| 87 |
27073670 | Chemotherapy continuity and incidence of febrile neutropenia with CHOP therapy in an outpatient setting. | 2016 Apr |
1 |
| 88 |
27129176 | Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II study. | 2016 May 31 |
1 |
| 89 |
27382104 | Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736. | 2016 Sep 1 |
1 |
| 90 |
27462230 | A Unique Hairy Cell Leukemia Variant. | 2016 May-Aug |
1 |
| 91 |
28030899 | Analysis of treatment outcomes for primary tonsillar lymphoma. | 2016 Dec |
1 |
| 92 |
28352766 | A rare case of primary pulmonary diffuse large B cell lymphoma with CD5 positive expression. | 2016 |
1 |
| 93 |
25430047 | Prognostic impact of the TP53 rs1625895 polymorphism in DLBCL patients. | 2015 Apr |
1 |
| 94 |
25635435 | Rituximab treatment strategy for patients with diffuse large B-cell lymphoma after first-line therapy: a systematic review and meta-analysis. | 2015 Feb 5 |
1 |
| 95 |
25648098 | Clinical Significance of Non-neutropenic Fever in the Management of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Comparison with Febrile Neutropenia and Risk Factor Analysis. | 2015 Jul |
1 |
| 96 |
25666327 | Progressive multifocal leukoencephalopathy (PML) in a patient with lymphoma treated with rituximab: A case report and literature review. | 2015 Sep-Oct |
1 |
| 97 |
25675909 | Disease characteristics, patterns of care, and survival in very elderly patients with diffuse large B-cell lymphoma. | 2015 Jun 1 |
2 |
| 98 |
25869285 | The biology and management of systemic anaplastic large cell lymphoma. | 2015 Jul 2 |
1 |
| 99 |
25878913 | Lymphocyte-Predominant Hodgkin's Disease in Children: A Case Study and Review of the Literature. | 2015 |
1 |
| 100 |
25881228 | Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models. | 2015 Apr 8 |
1 |